Adoptive cell transfer as personalized immunotherapy for human cancer. - Wikidata - awgldk - TriplyDB

Adoptive cell transfer as personalized immunotherapy for human cancer.

Adoptive cell transfer as personalized immunotherapy for human cancer.

http://www.wikidata.org/entity/Q34043643

about

A Perspective of Immunotherapy for Prostate Cancer Novel immunotherapeutic approaches to the treatment of urothelial carcinoma Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis Immune Cells in Cancer Therapy and Drug Delivery New Strategies for the Treatment of Solid Tumors with CAR-T Cells Surgical and molecular pathology of pancreatic neoplasms Adoptive immunotherapy against ovarian cancer Immunotherapy for cancer in the central nervous system: Current and future directions The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms Improving the clinical impact of biomaterials in cancer immunotherapy.Cellular and molecular biology of small cell lung cancer: an overview Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic Approaches Single-cell analysis tools for drug discovery and development Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy Precision medicine for cancer with next-generation functional diagnostics Trial Watch: Adoptive cell transfer for oncological indications T-Cell Therapy: Options for Infectious Diseases Synthetic biology approaches to engineer T cells Adoptive T-cell therapy for cancer: The era of engineered T cells Genetic instability in the tumor microenvironment: a new look at an old neighbor HIV-1 functional cure: will the dream come true?Structural Model of the Extracellular Assembly of the TCR-CD3 Complex.Melanoma cell lysosome secretory burst neutralizes the CTL-mediated cytotoxicity at the lytic synapse High-content molecular profiling of T-cell therapy in oncology Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic Future Therapy for Hepatitis B Virus: Role of Immunomodulators Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?Summary of emerging targets in anal cancer: the case for an immunotherapy based-approach Advances in Cancer Immunotherapy in Solid Tumors Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy Harnessing the Microbiome to Enhance Cancer Immunotherapy T cell exclusion, immune privilege, and the tumor microenvironment An Optimized GD2-Targeting Retroviral Cassette for More Potent and Safer Cellular Therapy of Neuroblastoma and Other Cancers Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?T-Cell Receptor-Engineered Cells for the Treatment of Hematologic Malignancies.Growth and Metastasis of Intraocular Tumors in Aged Mice.Longitudinal PET imaging demonstrates biphasic CAR T cell responses in survivors.

P2860

Q26741277-66FA5EF1-6F60-495C-A69F-4C305B23E856 Q26744347-133B02BD-0721-4F25-94F5-19E503494153 Q26746099-AFE87CCB-C3D5-4720-A894-1A48D2708F6F Q26747061-20E5228A-7E51-406F-A02C-5A82D52B1364 Q26748500-AD4A428D-CF2F-4D33-A445-D4E81101F663 Q26748615-37297118-0A28-4E4A-A990-35C5332BC1DE Q26748905-F58799BD-14AD-44EA-B6B4-B5C03C1D34F5 Q26750765-090B68BC-7A68-4B77-A24F-65A55599AD34 Q26765247-D5D2C0AD-6CF7-44C2-B32E-55F233C7B475 Q26766267-ACC2E04F-4005-416F-B537-24CF127B80D4 Q26767029-B61133BD-F6B6-48CF-A687-632CF10833C5 Q26774312-93A111B0-2B22-475A-8B47-00FD0C067678 Q26775754-7D003B2A-FFE5-4B4C-AB5A-32F285DD62AD Q26779938-D5DA52F1-8240-411D-BBD5-B834F641CBEB Q26780232-0DC6D572-5D76-42A0-B3A0-2F18DDAC465F Q26785545-7A1D5A50-1E9E-4073-9A9E-E72263D3486C Q26786661-06BB5367-68D7-42D1-AD18-A4EA99E059F7 Q26798366-7D6C33BB-7923-4C15-AC56-721B33BBA0A9 Q26800611-CCCF5301-AB3B-4F47-BA19-B6449C54D8B6 Q26801374-E0B00299-2C75-4C30-860A-697C89CE231F Q26865803-2EB10E80-BE30-49EC-8D07-93CEAABCF1F2 Q27319571-23728A4F-263D-428B-B62D-6DC61451AE66 Q27329598-BADD24D6-1C9F-4562-ACF2-57D16227B17B Q28066792-D4D91B2A-CCDD-4129-A135-C5FB6D46FF63 Q28068378-FCD4233D-02FF-46DF-997F-167E7CAC1F6E Q28074619-546F0A73-89F5-4CEA-90AE-FE47DB20ACD0 Q28075992-89C3FCCA-8636-4209-B066-73E35BC4EBE7 Q28078148-ABBF5D6D-242E-4E07-AFEE-6918A21556BA Q28078539-750270CB-CA9C-4C77-9B05-F20877E8C706 Q28080081-30B21C52-9F3A-4BEC-A807-EFAB643653EF Q28080113-7CD1F4DD-8EB0-4FAC-A1D3-3B13A295C254 Q28082914-F3F545E2-42B2-4FA2-9481-44C9C0C43ADE Q28088598-10E31876-FED9-4ACC-A4DC-C3C1F42DB797 Q28259872-C5191117-FA51-4D3F-9FE1-8244C767F200 Q28551080-EB50573C-2839-437B-A265-D84588E49CE0 Q28553650-872F59B3-5B04-458A-B18F-3C9D2D006B74 Q29994573-799B972D-5B1B-43E7-A103-7ADD4C9D0DA4 Q30251555-997EEF55-85B8-4649-B448-D66F960A1F9B Q30371011-9E574585-9FD5-4402-A52C-CBEC6313C344 Q30828860-DE98DBF9-E911-42DF-813F-970A123B222F

P2860

Adoptive cell transfer as personalized immunotherapy for human cancer.

http://www.wikidata.org/entity/Q34043643

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Adoptive cell transfer as personalized immunotherapy for human cancer.

@ast

Adoptive cell transfer as personalized immunotherapy for human cancer.

@en

Adoptive cell transfer as personalized immunotherapy for human cancer.

@nl

type

label

Adoptive cell transfer as personalized immunotherapy for human cancer.

@ast

Adoptive cell transfer as personalized immunotherapy for human cancer.

@en

Adoptive cell transfer as personalized immunotherapy for human cancer.

@nl

prefLabel

Adoptive cell transfer as personalized immunotherapy for human cancer.

@ast

Adoptive cell transfer as personalized immunotherapy for human cancer.

@en

Adoptive cell transfer as personalized immunotherapy for human cancer.

@nl

P1433

Q34043643-B323C57F-A50C-4211-82E2-AE0AD91C2356

P1476

Q34043643-60F66106-1F6B-45F8-A034-D26727172AB3

P2093

Q34043643-73501123-6A48-46EB-B597-76BCB4460590

P2860

Q34043643-00763DD4-DDB1-419A-B6D6-C95497F7C64A

Q34043643-0305D6F6-F476-4638-940E-31E6A4915C3E

Q34043643-074F2D4D-96A9-481B-93E5-3AF975A6E8DE

Q34043643-093AE338-6EE2-413F-B9AB-CFB856EC5411

Q34043643-09E618D0-9CB2-4B8F-9DD5-353EA7E2327C

Q34043643-09EE8E95-EF9F-4547-99C7-EA1655CB59D4

Q34043643-127D60B5-9A6B-4D86-8B4D-48E3D77DF1A0

Q34043643-182E1C58-FEB1-425E-9F3F-32B9EC32444F

Q34043643-18CD4231-9AF6-4254-8A84-93CBABF7D6F2

Q34043643-1BDCFB57-1C6F-47E4-9CA8-AB2529EDD156

P304

Q34043643-CAED37C2-64A7-4F97-98A6-C7EA70B52E29

P31

Q34043643-451E3A9B-5941-41C3-A41D-B4F944FD1334

P356

Q34043643-45675560-B408-42AA-9415-0E106C1167F4

P407

Q34043643-C1C569C8-BD7B-4F06-A199-8F8523BE1EFE

P433

Q34043643-CF299C3B-89A6-4E9E-9BE7-A30083421F33

P478

Q34043643-63F245C5-B2EC-4542-974A-95BDDB088C9A

P50

Q34043643-AB5BFA10-4C5F-4D7A-91CC-3350D93C3D1A

P577

Q34043643-14E531AA-5FE2-439A-8D1B-7BD66A86B935

P5875

Q34043643-1491AA4A-67BA-4F66-926E-5E4602AA273E

P698

Q34043643-58F92032-7EFD-4E4D-B6BE-365CCE2D8AFC

P921

Q34043643-42DFEBE4-9845-477A-9081-82EA1A967340

P932

Q34043643-0E6FD935-CBAC-4F32-BE3B-B849B0104DFB

P356

SCIENCE.AAA4967

P1433

P1476

Adoptive cell transfer as personalized immunotherapy for human cancer.

@en

P2093

Steven A Rosenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

Adoptive immunotherapy for cancer: building on success

Cancer immunotherapy: moving beyond current vaccines

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

P304

62-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.AAA4967

http://www.w3.org/2001/XMLSchema#string

P407

P433

6230

http://www.w3.org/2001/XMLSchema#string

P478

348

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas P. Restifo

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274739333

http://www.w3.org/2001/XMLSchema#string

P698

25838374

http://www.w3.org/2001/XMLSchema#string

P921

P932

6295668

http://www.w3.org/2001/XMLSchema#string